markus92

Bolt has a tiny bit of market share, Lyft is all but existent. Uber has a de facto monopoly in The Netherlands.

What kind of benefits do you mean? It’s a very common construction in The Netherlands.

Patient outcome, financially for the radiologist.

Auto import could be turned on?

Tell that to the antivaxers that attack vaccination sites and spread the propaganda.

Not necessarily true. The incidence rates of those are well-known. Rarer side effects are impossible to find by comparing vaccinated/unvaccinated in a phase 3 and need larger groups to be found. That’s routine, though. Look at the VITT for the Adenoviral vector vaccines, no strict control group was necessary to identify that.

That was Uber iirc

Any company that serves EU residents has to comply. If they block users from the EU, they don't have to comply. Fines can be massive (up to 2% global revenue).

Nexstar might not have any European assets, but non-compliance might not be a smart move if they get fined and business executives travel to Europe...

Many don’t fully cover the USA due to the exorbitant costs.

Phase 1 trial, just to see if they are fine and if there’s any major safety signals or not.

Wasn't allowed by the journal as it'd be considered prior publication. Used to be quite common in the medical field actually, COVID is slowly changing that luckily.

SoC has a bootloader exploit which makes it great for homebrew.

They'd only own the copyright on the minor change so can't force everyone to use GPL on all of the code.

Wasn’t at home, don’t have them in my Dropbox.

I’m a researcher at a first world university. I used sci-hub to pirate my own papers cus we did not have a subscription to the journal anymore. I’m not paying $39 to read my own work!

How can I verify that the QR code is of the person in front of me, if there's no name or anything included? Screenshots are old you know.

The person reading can use their eyes to read a passport/photo ID ;) You don't need an app to do that.

The Dutch app will have two QR codes: a national one which does hardly contains any information - initials and day/month of birth - and the EU DCC which is discussed here.

That would be considered off-label prescription.

And that's exactly why it should not be approved. There is no proof there is ANY effect on the disease outcome. The trial was halted prematurely for futility ffs! And now the FDA is giving people false hope? Letting them spend $65k/year for possible snake oil with no scientific evidence behind it?

Alzheimer's is a terrible disease. And I get it, you're willing to try anything for a possible improvement. Problem is, there is no proof at all that aducanumab leads to any kind of improvement: only stuff that you might find if you do tons of data mining to get the result you want. If the drug was that good, you would find it each and every time you try it, not one out of a hundred times if you look at a subset of a subset.

The only reason the Biogen wants approval of this drug, is to earn money out of desperate people willing to try anything. The FDA should be there to protect people from this. They have failed to do that here.

But how many have commercially available/succesful products?

That was added after this scandal first unearthed.

That's exactly what it is. Reasoning being two-fold, first is that it's easy to implement as the government knows the exact payroll of every company anyways (they file taxes quarterly), second is to keep people on the payroll in case restrictions can be loosened. They're still working, so can go back to productivity immediately.

The "I send you a tikkie for this .25ct tomato paste can"-meme.

The energy requirements are vastly different, rolling stock is a lot cheaper than airframes etc.

You don't click. When you open the app, the first thing you see is a "random" video (selected by their creepily good algorithm). Watched it or don't like it? Swipe through and the next video instantly starts. The app is good at figuring out which videos get engaged with and promotes these.

Though there is the functionality to go to user profiles and click videos, like on Instagram and such, it's not the main functionality of the app.

That's why there's digital qPCR now, testing has come a long way since 1993. Larger targets etc.

Basically this. You need four consecutive batches with consistent quality in a row for approval.

Not relevant if your model doesn't fit in GPU memory.

Easy to say but not necessarily true. Let's look at the Halix factory, which is the main point of contention in the EU/UK dispute. The Dutch government (thus, EU) already offered them a major contract in March/April '20, for precisely this purpose. They already had started expanding in Feb '20 as part of their production for the AZ trial, so they declined.